Back to company

Biotech Force Danmark ApS: Financial statements 2024

CVR: 36434309

Biotech Force Danmark ApS (CVR 36434309) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,647,922 and a net result of DKK -2,161,531 compared with DKK -11,723,160 the year before. Equity amounted to DKK -14,206,012.

Gross Profit
-2,647,922 kr.
Profit/Loss
-2,161,531 kr.
Equity
-14,206,012 kr.
Total Assets
14,734,278 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--2.6 mio.-2.2 mio.-14.2 mio.-
2023--2.4 mio.-11.7 mio.-12 mio.-
2022--3 mio.-2.7 mio.-321 t.-
2021--1.9 mio.-2.3 mio.2.4 mio.-
2020--1.5 mio.-1.9 mio.4.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Biotech Force Danmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Biotech Force Danmark ApS: The 2023 annual report is outJul 12, 2024

Biotech Force Danmark ApS has published its annual report for 2023. Gross profit came to DKK -2,418,679, and the net result was DKK -11,723,160.

About Biotech Force Danmark ApS

Biotech Force Danmark ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2014. The company is registered under the industry Engroshandel med rengøringsmidler. The company was previously named ANTi-COVID 19 Danmark ApS and GL. DONSVEJ 6 KOLDING ApS. The management consists of Jette Kjærgaard. The company's owners include JMR HOLDING, KOLDING A/S, PLAN Invest A/S and Reinert Family Invest ApS. In 2025, the company reported a gross profit of DKK -3,515,065 and a net result of DKK -4,321,793 compared with DKK -2,161,531 the year before. Equity amounted to DKK -18,527,805.